C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C07K 14/705 (2006.01) C12Q 1/02 (2006.01) G01N 33/50 (2006.01) G01N 33/566 (2006.01) G01N 33/94 (2006.01)
Patent
CA 2160038
This invention relates to the use of reagents in a novel manner to screen compounds in vitro for their ability to interact with and modulate the functional properties of receptors coupled to guanyl nucleotide-binding regulatory proteins (G-proteins).Methods are described herein for determining the ability of compounds to act as antagonists by observing their ability to downregulate recombinant G-protein coupled receptors in membrane preparations. The methods described permit the downregulation effect to be observed within a time frame that is dramatically accelerated compared to other known methods of testing the same effect, thereby providing novel and improved efficient means of screening compounds for their probable pharmaceutical efficacy. This invention also relates to the use of such reagents and methods in kits.
Bouvier Michel
Chidiac Peter
Dennis Michael
Labrecque Jean
Biosignal Inc.
Bouvier Michel
Chidiac Peter
Dennis Michael
Labrecque Jean
LandOfFree
Methods of screening compounds for their pharmacological... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of screening compounds for their pharmacological..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of screening compounds for their pharmacological... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2083203